PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Extract alleviates senescence in lung fibroblasts via PI3K/Akt signaling in mouse models [PMID:39326135]
Sang-Bai-Pi extract (specifically fraction EA-3) and regiafuran C ameliorate renal fibrosis in UUO rat models [PMID:39756310]
Prenylated flavanones show α-glucosidase inhibitory activity [PMID:39102223]; extract shows hypoglycemic activity in STZ-induced diabetic rats [PMID:38253278]
Methanolic extract (MEMARB) reduces serum amylase, lipase, and inflammatory markers in alcohol/cerulein-induced rat models [PMID:30335608, 30302330]
Ethyl acetate fraction reduced heart weight and serum renin/angiotensinogen levels in high-salt diet mice [PMID:38790847]
Evidence summary
PubMed sources
- 1.PMID: 39326135 (2024) — Cortex Mori Radicis[Morus Alba L. (Moraceae)] extract alleviates senescence via PI3K/Akt signaling in COPD fibroblasts. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 2.PMID: 39756310 (2025) — Sang-Bai-Pi extract and its constituent regiafuran C ameliorate renal fibrosis through TGF-β/Smad and Wnt/β-catenin signaling pathways. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 3.PMID: 39102223 (2024) — Prenylated Flavanone Enantiomers with α-Glucosidase Inhibitory Activity from the Root Bark of Morus alba. · Chemistry & biodiversity
- 4.PMID: 40510163 (2025) — Molecular targets and mechanisms of cortex mori for lung cancer treatment: a network pharmacology study, molecular docking and in vitro and in vivo experimental validation. · Frontiers in oncology
- 5.PMID: 40840729